Boeing vs. Lockheed Martin: Which Aerospace Stock Is a Better Buy in 2026?

The article frames Boeing (BA) vs. Lockheed Martin (LMT) as a choice between a turnaround and a defense “core.” Boeing reported FY2025 revenue of ~$89.5B (+34.5% YoY) with net income of ~$2.2B and improved net margin to ~2.5%, but free cash flow was still about -$1.9B and debt-to-equity was ~10x; it also flags execution risks (FAA certification/production delays and Spirit AeroSystems integration). Lockheed’s FY2025 revenue was ~$75.1B (+5.7%), net income just over $5B, with strong free cash flow of ~$6.9B and lower leverage (debt-to-equity ~3.2x), supported by the F-35 program (~27% of revenue) and U.S. government dependence (~72% of sales). Valuation is cited as materially cheaper for Lockheed (forward P/E ~16.5x) versus Boeing (forward P/E ~49x), with Boeing forecast to have much lower net income (~$85M) despite higher revenue growth (~+9% to ~$97.7B).

Analysis

The market is likely still mispricing the asymmetry between a turnaround equity and a cash-generative defense compounder. BA is trading like an execution story that has already been de-risked, but with leverage still high and cash conversion fragile, any incremental hiccup in certification, production cadence, or supplier integration should hit equity disproportionately; the downside is convex because balance-sheet repair is the real bottleneck, not demand.

LMT is the opposite: a quasi-bond proxy with embedded program concentration. In the next 1-3 months, it should keep earning a scarcity premium versus defense peers because capital return visibility matters more than growth, but over 6-18 months the market may start to discount budget concentration and program-specific risk more heavily if procurement cycles tighten or export/technology review slows orders. The hidden beneficiary of BA weakness is Airbus, which can convert any Boeing disruption into share gains and pricing power across narrowbody and widebody demand.

The contrarian point is that consensus is treating LMT as the safer long while underestimating how much of that safety rests on one franchise and political throughput. Conversely, the BA rebound case may be too dependent on multiple years of flawless execution; that is hard to underwrite when FCF is still not self-funding and the company remains vulnerable to any working-capital or delivery slippage. This setup favors relative-value over outright directional exposure.

Key Decisions for Investors

• Long LMT / short BA as a 6-12 month pair trade; target 15-20% relative outperformance if BA continues to de-rate on execution risk while LMT holds its capital-return premium. Cut if BA shows two consecutive quarters of positive free cash flow without material working-capital distortion.
• For portfolios needing aerospace beta, express it via EADSY/EADSF over BA on any pullback: Airbus should capture share and pricing spillover if Boeing’s supply chain or certification timeline slips again. This is a cleaner way to own the commercial-cycle beneficiary than paying for BA turnaround optionality.
• Underweight SPR on BA integration risk; if Spirit becomes a recurring cost-overrun story, the supplier may be forced into concessions that protect Boeing’s OEM margins later but pressure near-term sentiment. Watch for renegotiation headlines or margin guidance cuts as the falsifier.
• If entering LMT, do it on weakness rather than chasing strength: the stock should hold up on defense-budget inertia, but upside is likely capped unless the market gets new evidence of F-35 or missile-margin acceleration. Use a 3-6 month horizon and exit if program concentration risk reappears in guidance.
• Avoid a blanket long defense basket. Prefer LMT over GD/NOC/RTX only if the market is rewarding program durability; otherwise a pair like long LMT / short XLI can hedge macro while keeping the idiosyncratic defense premium.